WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001029229) NOVEL POLYPEPTIDE, HUMAN RETINOBLASTOMA BINDING PROTEIN 20 AND POLYNUCLEOTIDE ENCODING IT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/029229    International Application No.:    PCT/CN2000/000331
Publication Date: 26.04.2001 International Filing Date: 16.10.2000
Chapter 2 Demand Filed:    18.05.2001    
IPC:
A61K 38/00 (2006.01), C07K 14/47 (2006.01)
Applicants: SHANGHAI BIO ROAD GENE DEVELOPMENT LTD. [CN/CN]; 3rd Building, 12th floor, 1111 Zhongshan Bei Er Road, Shanghai 200092 (CN) (For All Designated States Except US).
MAO, Yumin [CN/CN]; (CN) (For US Only).
XIE, Yi [CN/CN]; (CN) (For US Only)
Inventors: MAO, Yumin; (CN).
XIE, Yi; (CN)
Agent: SHANGHAI ZHI XIN PATENT AGENT LTD.; 10/F, Italy Building, Zhao Jia Bang Road, Shanghai 200031 (CN)
Priority Data:
99 1 16989.1 18.10.1999 CN
Title (EN) NOVEL POLYPEPTIDE, HUMAN RETINOBLASTOMA BINDING PROTEIN 20 AND POLYNUCLEOTIDE ENCODING IT
(FR) NOUVEAU POLYPEPTIDE, PROTEINE HUMAINE 20 DE LIAISON DE RETINOBLASTOME ET POLYNUCLEOTIDE LE CODANT
Abstract: front page image
(EN)The invention concerns human retinoblastoma binding protein 20 and polynucleotide encoding it. The invention also concerns the process of producing the polypeptide by recombinant DNA technique. The methods for treating many diseases e.g. malignant tumor, hemopathy, infection of HIV, immunological diseases and pruritus utilizing the polypeptide are disclosed. The invention discloses the antagonist against the polypeptide and therapeutics thereof. The invention also discloses the uses of the polynucleotide, which encodes the human retinoblastoma binding protein 20.
(FR)L'invention concerne un nouveau polypeptide, une protéine humaine 20 de liaison de rétinoblastome, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des tumeurs malignes, de l'hémopathie, de l'infection par VIH, de maladies immunitaires et du prurit. L'invention concerne aussi l'agoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour la nouvelle protéine humaine 20 de liaison de rétinoblastome.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)